From the *Division of Nuclear Medicine, Department of Radiology, †Department of Otolaryngology, and ‡Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.
Clin Nucl Med. 2015 Jun;40(6):476-82. doi: 10.1097/RLU.0000000000000778.
There is uncertainty about accuracies of dual-phase (DP) and dual-tracer (DT) parathyroid scintigraphy with the newly added SPECT/CT. Although SPECT/CT was shown to be helpful in parathyroid adenoma (PA) localization, it may not have optimal resolution as pinhole. This study directly compared diagnostic accuracies and confidences of various imaging protocols on same patients.
One hundred fifty-five patients with pathologically confirmed diagnosis were included. Pinhole DP, pinhole DT, pinhole DP SPECT/CT, pinhole DT SPECT/CT, and SPECT/CT with only pinhole-delayed MIBI (D) were reviewed for accuracies and certainties of PA diagnosis/localization. Parathyroid adenomas were classified as clearly or unclearly distinguishable from thyroid. Furthermore, the contribution of pinhole DP to pinhole DT SPECT/CT was assessed.
Of 153 PAs, the correct diagnosis/localization was significantly higher by pinhole DT SPECT/CT than pinhole DP SPECT/CT, SPECT/CT D, pinhole DT alone, and DP alone. Parathyroid adenomas were clearly more distinguished from thyroid in pinhole DT than DP with/without SPECT/CT. Consequently, PA diagnosis certainty was higher in pinhole DT than DP, whereas PA localization certainty was higher in both with SPECT/CT. In pinhole DT SPECT/CT, the pinhole DP addition confirmed diagnosis/localization of only 24 uncertain PAs.
In this large patient group, the accuracy and certainty of PA diagnosis/localization were higher in pinhole DT SPECT/CT than all other parathyroid scintigraphy protocols. Pinhole DT better identified PA than pinhole DP, whereas SPECT/CT improved PA localization in both protocols. Pinhole DP showed limited contribution and thus should be only considered when PA diagnosis/localization is uncertain by pinhole DT SPECT/CT.
新增加的单光子发射计算机断层扫描(SPECT)技术使双相(DP)和双示踪剂(DT)甲状旁腺闪烁成像的准确性存在不确定性。虽然 SPECT 已被证明有助于甲状旁腺腺瘤(PA)的定位,但它的分辨率可能不如针孔。本研究直接比较了各种成像方案在同批患者中的诊断准确性和置信度。
共纳入 155 例经病理证实的患者。对针孔 DP、针孔 DT、针孔 DP SPECT/CT、针孔 DT SPECT/CT 和仅使用针孔延迟 MIBI(D)的 SPECT/CT 进行回顾性分析,以评估 PA 诊断/定位的准确性和置信度。甲状旁腺腺瘤被分为与甲状腺明显可区分或不可区分。此外,还评估了针孔 DP 对针孔 DT SPECT/CT 的贡献。
在 153 个 PA 中,针孔 DT SPECT/CT 的正确诊断/定位明显高于针孔 DP SPECT/CT、SPECT/CT D、单独针孔 DT 和单独 DP。与 DP 相比,针孔 DT 能更清晰地区分甲状旁腺腺瘤与甲状腺。因此,针孔 DT 的 PA 诊断置信度高于 DP,而 SPECT/CT 则提高了两者的 PA 定位置信度。在针孔 DT SPECT/CT 中,针孔 DP 的添加仅确认了 24 个不确定 PA 的诊断/定位。
在这个大型患者群体中,针孔 DT SPECT/CT 的 PA 诊断/定位准确性和置信度均高于其他所有甲状旁腺闪烁成像方案。针孔 DT 比针孔 DP 更能识别 PA,而 SPECT/CT 则改善了两种方案中的 PA 定位。针孔 DP 的贡献有限,因此只有在针孔 DT SPECT/CT 不确定 PA 诊断/定位时才应考虑。